Hoxton Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Hoxton Financial’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$347K	Buy	12,417 +5,412	+77%	+$118K	0.18%	50
2015 Q4	$250K	Sell	7,005 -6,485	-48%	-$228K	0.12%	63
2015 Q3	$446K	Buy	13,490 +7,893	+141%	+$328K	0.21%	37
2015 Q2	$234K	Buy	5,597 +1,252	+29%	+$48.5K	0.1%	71
2015 Q1	$142K	Sell	4,345 -767	-15%	-$26.4K	0.06%	94
2014 Q4	$162K	Sell	5,112 -193	-4%	-$5.47K	0.07%	91
2014 Q3	$131K	Sell	5,305 -218	-4%	-$5.1K	0.06%	93
2014 Q2	$125K	Sell	5,523 -1,994	-27%	-$41.6K	0.05%	96
2014 Q1	$183K	Buy	7,517 +2,091	+39%	+$52.9K	0.08%	74
2013 Q4	$136K	Buy	+5,426	New	+$128K	0.06%	110

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Hoxton Financial's ACAD Position: Q1 2016 in Review

Hoxton Financial increased its Acadia Pharmaceuticals (ACAD) stake by 77% in Q1 2016, buying an estimated $118K and bringing the position to 12,417 shares worth $347K. The position accounts for 0.18% of the portfolio, ranked #50.

Hoxton Financial first reported a position in ACAD in Q4 2013 and has held it in 10 quarters since. The position peaked at $446K in Q3 2015. 213 funds tracked by Wall St. Rank hold ACAD as of Q1 2016.

Hoxton Financial held 12,417 shares of Acadia Pharmaceuticals worth $347K as of Q1 2016.
Hoxton Financial bought 5,412 Acadia Pharmaceuticals shares in Q1 2016, an estimated $118K.
Acadia Pharmaceuticals made up 0.18% of Hoxton Financial's portfolio in Q1 2016, its #50 holding.
Hoxton Financial first reported a position in Acadia Pharmaceuticals in Q4 2013 and has held it in 10 quarters since.
Hoxton Financial's Acadia Pharmaceuticals position peaked at $446K in Q3 2015.
213 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.